Mini review · 30 Jun 2022
Conference abstractPublished 23 Jan 2022
Development of a skin- and neuro-attenuated live vaccine for varicella
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Varicella caused by the primary infection of a ubiquitous neurotropic human alpha-herpesvirus, varicella-zoster virus (VZV), exerts a considerable disease burden worldwide. The current live Varicella Vaccine Strain (vOka) is generally safe and effective. However, vOka retains full ability to cause mild varicella, establish latency and reactivate to cause herpes zoster that is often clinically indistinguishable from wild-type disease in vaccine recipients. These adverse effects could be the result from vOka haplotypes carrying the disease-causing alleles, raising safety concerns. Therefore, there is a need for next-generation varicella vaccines with reduced pathogenic risk to improve the current strategy for establishing worldwide herd immunity against this disease.
Keywords
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Experimental and Clinical Microbiology.
Review article · 25 May 2022
Fungal coinfections in COVID-19 patients – current evidence and future directions
Short communication · 27 Apr 2022
MDR Tuberculosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Experimental and Clinical Microbiology
- SubjectMicrobiology
- BylineArticles whose byline prints “Hua Zhu”
